School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China.
School of Pharmacy, China Pharmaceutical University, Nanjing, 211198, People's Republic of China; State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 210009, People's Republic of China.
Chem Biol Interact. 2022 Jan 5;351:109746. doi: 10.1016/j.cbi.2021.109746. Epub 2021 Nov 13.
Human aldo-keto reductase family 1C1 (AKR1C1) is an important enzyme involved in human hormone metabolism, which is mainly responsible for the metabolism of progesterone in the human body. AKR1C1 is highly expressed and has an important relationship with the occurrence and development of various diseases, especially some cancers related to hormone metabolism. Nowadays, many inhibitors against AKR1C1 have been discovered, including some synthetic compounds and natural products, which have certain inhibitory activity against AKR1C1 at the target level. Here we briefly reviewed the physiological and pathological functions of AKR1C1 and the relationship with the disease, and then summarized the development of AKR1C1 inhibitors, elucidated the interaction between inhibitors and AKR1C1 through molecular docking results and existing co-crystal structures. Finally, we discussed the design ideals of selective AKR1C1 inhibitors from the perspective of AKR1C1 structure, discussed the prospects of AKR1C1 in the treatment of human diseases in terms of biomarkers, pre-receptor regulation and single nucleotide polymorphisms, aiming to provide new ideas for drug research targeting AKR1C1.
人醛酮还原酶家族 1C1(AKR1C1)是参与人体激素代谢的重要酶,主要负责人体中孕酮的代谢。AKR1C1 表达水平高,与各种疾病的发生发展密切相关,特别是与激素代谢相关的一些癌症。目前已经发现了许多针对 AKR1C1 的抑制剂,包括一些合成化合物和天然产物,它们在靶标水平上对 AKR1C1 具有一定的抑制活性。本文简要综述了 AKR1C1 的生理病理功能及其与疾病的关系,总结了 AKR1C1 抑制剂的发展,并通过分子对接结果和现有共晶结构阐明了抑制剂与 AKR1C1 的相互作用。最后,从 AKR1C1 结构的角度探讨了选择性 AKR1C1 抑制剂的设计理念,从生物标志物、受体前调节和单核苷酸多态性等方面讨论了 AKR1C1 在人类疾病治疗中的前景,旨在为靶向 AKR1C1 的药物研究提供新的思路。